Tilray Medical Cannabis

Tilray is a global pioneer in the research, cultivation, production, and distribution of medical cannabis and cannabinoid-based products. Founded in 2013, the brand emerged as one of the first companies to receive a license to cultivate and sell medical cannabis under Canadian federal regulations.

The manufacturing and cultivation of Tilray products occur across a diverse international footprint. The company operates major production facilities in Canada and has established a significant European hub with a state-of-the-art facility in Cantanhede, Portugal. This strategic presence allows the brand to serve patients and healthcare providers across several continents, maintaining rigorous pharmaceutical-grade standards such as Good Manufacturing Practices (GMP).

In 2021, Tilray underwent a transformative business combination with Aphria Inc. While the combined company retained the Tilray name, the merger created the largest global cannabis company by revenue at the time. Today, Tilray Brands, Inc. is a diversified lifestyle and consumer packaged goods company with a portfolio that extends beyond medical cannabis into craft beer, spirits, and hemp-based food products.